[
  {
    "ts": null,
    "headline": "Company News for Apr 25, 2025",
    "summary": "Companies in The News Are: BMY,MRK,PEP,UNP",
    "url": "https://finnhub.io/api/news?id=9bf0d652802c7e641f587e0b5ff39ea70ba6b1b50affbfac241974041d0aedf6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745587500,
      "headline": "Company News for Apr 25, 2025",
      "id": 134087727,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Companies in The News Are: BMY,MRK,PEP,UNP",
      "url": "https://finnhub.io/api/news?id=9bf0d652802c7e641f587e0b5ff39ea70ba6b1b50affbfac241974041d0aedf6"
    }
  },
  {
    "ts": null,
    "headline": "Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields.",
    "summary": "Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields.",
    "url": "https://finnhub.io/api/news?id=2e29dc4f360a59dca1d05fb47b3f29db02f3947140f1ca36402cd0b93f972bc3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745586000,
      "headline": "Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields.",
      "id": 134150128,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields.",
      "url": "https://finnhub.io/api/news?id=2e29dc4f360a59dca1d05fb47b3f29db02f3947140f1ca36402cd0b93f972bc3"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (BMY): A Growing Dividend Stock with Low PE Ratio",
    "summary": "We recently published a list of the 30 Growing Dividend Stocks with Low PE Ratios. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other growing dividend stocks. Value stocks are enjoying a rare period of strength amid this year’s broader market downturn. With earnings season approaching, […]",
    "url": "https://finnhub.io/api/news?id=b323f486cc3ce2204637130253c4e77faf21113abb70c7ae35abc372f3a44721",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745584645,
      "headline": "Bristol-Myers Squibb Company (BMY): A Growing Dividend Stock with Low PE Ratio",
      "id": 134087924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of the 30 Growing Dividend Stocks with Low PE Ratios. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other growing dividend stocks. Value stocks are enjoying a rare period of strength amid this year’s broader market downturn. With earnings season approaching, […]",
      "url": "https://finnhub.io/api/news?id=b323f486cc3ce2204637130253c4e77faf21113abb70c7ae35abc372f3a44721"
    }
  },
  {
    "ts": null,
    "headline": "5 Positives From Bristol-Myers Squibb's Q1 2025 Results",
    "summary": "Bristol-Myers Squibb raised its 2025 EPS outlook after a Q1 beat, with shares trading far below historical P/E levels. Find out why BMY stock is a buy.",
    "url": "https://finnhub.io/api/news?id=eb10c934b299efd670941ab32517b7092ef6a7d582cc60022b8974e1b4da8bb4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745576826,
      "headline": "5 Positives From Bristol-Myers Squibb's Q1 2025 Results",
      "id": 134082457,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160008492/image_2160008492.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb raised its 2025 EPS outlook after a Q1 beat, with shares trading far below historical P/E levels. Find out why BMY stock is a buy.",
      "url": "https://finnhub.io/api/news?id=eb10c934b299efd670941ab32517b7092ef6a7d582cc60022b8974e1b4da8bb4"
    }
  },
  {
    "ts": null,
    "headline": "Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?",
    "summary": "Biogenâs lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.",
    "url": "https://finnhub.io/api/news?id=ef3adb4bcd126997d1f1592527ecb2afc521115bd3cda32b4212595c2984fefe",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745572551,
      "headline": "Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?",
      "id": 134077371,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2165724853/image_2165724853.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Biogenâs lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.",
      "url": "https://finnhub.io/api/news?id=ef3adb4bcd126997d1f1592527ecb2afc521115bd3cda32b4212595c2984fefe"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers: Undervalued, Delivering Increased 2025 Guidance",
    "summary": "Bristol-Myers Squibb's strong profitability, significant drug growth, and low valuation provide great upside potential. Read why BMY stock is a strong buy.",
    "url": "https://finnhub.io/api/news?id=419de6e7ba60849d842c51ec00e1701b81a9111270078322d94fa69a9d817094",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745571600,
      "headline": "Bristol-Myers: Undervalued, Delivering Increased 2025 Guidance",
      "id": 134076510,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810122/image_1445810122.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb's strong profitability, significant drug growth, and low valuation provide great upside potential. Read why BMY stock is a strong buy.",
      "url": "https://finnhub.io/api/news?id=419de6e7ba60849d842c51ec00e1701b81a9111270078322d94fa69a9d817094"
    }
  }
]